Q2 2024 · 13F-HR
MFN Partners Management, LPholdings as filed
Filed 2024-08-12 · accession 0000904454-24-000456
$2.95B
Reported value
10
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 983793100 | XPO | XPO INC | $1.21B | 41.1% | 11,425,369 | Common | SOLE |
| 74982T103 | RXO | RXO INC | $452.7M | 15.3% | 17,310,856 | Common | SOLE |
| 70932M107 | PFSI | PENNYMAC FINL SVCS INC NEW | $428.7M | 14.5% | 4,531,792 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $312.9M | 10.6% | 973,898 | Common | SOLE |
| 674599162 | OXY/WS | OCCIDENTAL PETE CORP | $234.2M | 7.94% | 5,690,600 | Common | SOLE |
| 536797103 | LAD | LITHIA MTRS INC | $224.7M | 7.62% | 890,000 | Common | SOLE |
| 071734107 | BHC | BAUSCH HEALTH COS INC | $41.8M | 1.42% | 6,000,000 | Common | SOLE |
| 46578C108 | IE | IVANHOE ELECTRIC INC | $23.9M | 0.81% | 2,553,191 | Common | SOLE |
| 349853101 | FWRDUSD | FORWARD AIR CORP | $17.2M | 0.58% | 903,777 | Common | SOLE |
| 23255M204 | CYCN | CYCLERION THERAPEUTICS INC | $386,369 | 0.01% | 169,460 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.